---
title: "Jefferies Reaffirms Their Buy Rating on Abbott Laboratories (ABT)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293045497.md"
description: "Jefferies reaffirmed a Buy rating on Abbott Laboratories (ABT) with a $135 price target. Additionally, Citi maintained a Buy rating on the stock with a $112 price target."
datetime: "2026-07-17T13:35:24.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293045497.md)
  - [en](https://longbridge.com/en/news/293045497.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293045497.md)
generator: "portal-rs"
---

# Jefferies Reaffirms Their Buy Rating on Abbott Laboratories (ABT)

Jefferies analyst reiterated a Buy rating on Abbott Laboratories today and set a price target of $135.00.

### TipRanks Welcomes a New ETF – NYSE:RANK

-   TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE.
-   RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.

In a report released today, Citi also maintained a Buy rating on the stock with a $112.00 price target.

### Related Stocks

- [ABT.US](https://longbridge.com/en/quote/ABT.US.md)
- [JEF.US](https://longbridge.com/en/quote/JEF.US.md)
- [RANK.US](https://longbridge.com/en/quote/RANK.US.md)
- [C.US](https://longbridge.com/en/quote/C.US.md)
- [C-R.US](https://longbridge.com/en/quote/C-R.US.md)

## Related News & Research

- [IFP Advisors Inc Grows Stock Holdings in Abbott Laboratories $ABT](https://longbridge.com/en/news/298421693.md)
- [Amundi Grows Position in Abbott Laboratories $ABT](https://longbridge.com/en/news/298275328.md)
- [Abbott to pay $384 million over contaminated infant formula allegations, US Justice Dept says](https://longbridge.com/en/news/298950554.md)
- [Abbott reaches agreement with Department of Justice to resolve claims relating to 2022 infant formula recall | ABT Stock News](https://longbridge.com/en/news/298942114.md)
- [Abbott receives FDA approval for its TactiFlex™ Duo Ablation Catheter to treat people with abnormal heart rhythms](https://longbridge.com/en/news/298316210.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**